The GS1 System of Standards for Healthcare has been endorsed by more than 30 leading healthcare stakeholders from around the world.
Expressing their strong support in a signed position paper endorsing the adoption of GS1 as the global standard best suited for their industry, the healthcare stakeholders made the endorsement following the publication of a McKinsey & Company white paper, which stated that ‘significant patient safety benefits and cost savings can be obtained by implementing and using a single global standard in healthcare’.
These stakeholders represent major manufacturers, distributors and hospitals around the world including the United States, Canada, Europe, Australia and Japan. The companies include 3M, Abbott, Apotex, Axway, Baxter, Bayer, BD, B.Braun, Boehringer Ingelheim, Canadian Generic Pharmaceutical Association, Cardinal Health, CH2, Covidien, Fedefarma, Fresenius Kabi, Johnson & Johnson, McKesson, Mölnlycke, Novation, Pfizer, Premier, RX360 and Sanofi Pasteur.
Hospitals and Group Purchasing Organisations endorsing GS1 Healthcare Standards in the position paper include Novation and Premier in the United States, St. James Hospital in Ireland, the Department of Health UK for all NHS hospitals, Logaritme, Province of Catalonia in Spain, Hospital Centre Robert Ballanger, Hospital Centre of Brive, Hospital Centre Rene Dubois, Hospital Sud Francilien, University Hospital of Strasbourg, University Hospital of Dijon and Hospital Centre of Coulommiers in France, and NTT Medical Center Tokyo in Japan.
The healthcare leaders state in the position paper: ‘As GS1 Standards for Healthcare were developed and became available over the last few years, healthcare communities across the globe have embraced them and advanced their implementation... GS1 Standards enable streamlined supply chain processes and improve visibility – from manufacturers to patients’.
Orlando Serani, Vice President, Global Business Services, Johnson & Johnson Health Care Systems Inc. observes that global adoption of the GS1 Standards will clearly benefit patients and industry stakeholders worldwide.
GS1 CEO Miguel Lopera from the GS1 Global Office in Brussels comments that GS1 welcomes the endorsement of the GS1 System of Standards for Healthcare by so many leading stakeholders in the global healthcare industry. He adds that all of the members of the GS1 Healthcare team have worked hard to ensure that GS1 Healthcare Standards maximise patient safety, optimise supply chain efficiency and minimise costs for all partners in the supply chain.
Healthcare systems around the world are facing challenges that affect the entire supply chain, from manufacturers to wholesalers, distributors, group purchasing organisations and healthcare providers. Issues such as counterfeiting, ineffective product recall and medication errors are creating these challenges and impacting the entire healthcare supply chain. Stemming these soaring costs has become a major policy priority for healthcare trading partners.
Implementing global standards across the entire healthcare supply chain could save 22,000 - 43,000 lives and avert 0.7 to 1.4 million patient disabilities, according to the McKinsey report. Called ‘Strength in unity: The promise of global standards in Healthcare’, the report is based on interviews with 80 thought leaders in the healthcare industry. The report also found that rolling out a single, global standards-based system will:
- Keep tens of billions of dollars in counterfeit drugs out of the legitimate supply chain
- Enable substantial safety benefits that would reduce healthcare costs by $40-100 billion
- Cost significantly less than two or more systems